XML 84 R75.htm IDEA: XBRL DOCUMENT v3.23.3
Capital Stock (Stock Option, SARs, Restricted Stock and Restricted Share Unit Activity) (Details)
shares in Millions
6 Months Ended
Sep. 30, 2023
$ / shares
shares
Class A Voting Shares | Stock Options and SARs  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Outstanding at March 31, 2023 (in shares) 4.3
Granted (in shares) 0.0
Options exercised (in shares) 0.0
Forfeited or expired (in shares) (1.8)
Outstanding at September 30. 2023 (in shares) 2.5
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]  
Outstanding at March 31, 2023, weighted average exercise price (in usd per share) | $ / shares $ 26.35
Granted, weighted average exercise price (in usd per share) | $ / shares 0
Options exercised, weighted average exercise price (in usd per share) | $ / shares 7.70
Forfeited or expired, weighted average exercise price (in usd per share) | $ / shares 30.79
Outstanding at September 30, 2023, weighted average exercise price (in usd per share) | $ / shares $ 22.99
Class A Voting Shares | Restricted Stock and Restricted Share Units (RSUs)  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Outstanding at March 31, 2023 (in shares) 0.0
Granted (in shares) 0.0
Vested (in shares) 0.0
Forfeited or expired (in shares) 0.0
Outstanding at September 30, 2023 (in shares) 0.0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Outstanding at March 31, 2023, weighted average grant-date fair value (in usd per share) | $ / shares $ 10.95
Granted, weighted average grant date fair value (in usd per share) | $ / shares 0
Restricted stock or RSUs vested, weighted average grant-date fair value (in usd per share) | $ / shares 10.89
Forfeited or expired, weighted average grant-date fair value (in usd per share) | $ / shares 0
Outstanding at September 30, 2023, weighted average grant-date fair value (in usd per share) | $ / shares $ 11.01
Class B Non-Voting Shares | Stock Options and SARs  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Outstanding at March 31, 2023 (in shares) 20.5
Granted (in shares) 0.0
Options exercised (in shares) (0.1)
Forfeited or expired (in shares) (2.1)
Outstanding at September 30. 2023 (in shares) 18.3
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]  
Outstanding at March 31, 2023, weighted average exercise price (in usd per share) | $ / shares $ 15.23
Granted, weighted average exercise price (in usd per share) | $ / shares 0
Options exercised, weighted average exercise price (in usd per share) | $ / shares 7.15
Forfeited or expired, weighted average exercise price (in usd per share) | $ / shares 29.19
Outstanding at September 30, 2023, weighted average exercise price (in usd per share) | $ / shares $ 13.82
Class B Non-Voting Shares | Restricted Stock and Restricted Share Units (RSUs)  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Outstanding at March 31, 2023 (in shares) 14.0
Granted (in shares) 9.2
Vested (in shares) (9.1)
Forfeited or expired (in shares) (0.5)
Outstanding at September 30, 2023 (in shares) 13.6
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Outstanding at March 31, 2023, weighted average grant-date fair value (in usd per share) | $ / shares $ 9.48
Granted, weighted average grant date fair value (in usd per share) | $ / shares 8.19
Restricted stock or RSUs vested, weighted average grant-date fair value (in usd per share) | $ / shares 9.33
Forfeited or expired, weighted average grant-date fair value (in usd per share) | $ / shares 8.77
Outstanding at September 30, 2023, weighted average grant-date fair value (in usd per share) | $ / shares $ 8.73
Maximum | Class A Voting Shares | Stock Options and SARs  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Options exercised (in shares) (0.1)
Forfeited or expired (in shares) (0.1)
Maximum | Class A Voting Shares | Restricted Stock and Restricted Share Units (RSUs)  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Outstanding at March 31, 2023 (in shares) 0.1
Outstanding at September 30, 2023 (in shares) 0.1
Maximum | Class B Non-Voting Shares | Stock Options and SARs  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Granted (in shares) 0.1